COCRYSTAL PHARMA, INC. Deferred Tax Assets, Operating Loss Carryforwards
COCRYSTAL PHARMA, INC. (COCP) had Deferred Tax Assets, Operating Loss Carryforwards of $26.32 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.32M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $23.67M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.00M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.37M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $26.32M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $23.67M 10-K · filed 2026-03-31 | |
| 2023-12-31 | $22.00M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $21.37M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $19.99M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $17.24M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $15.41M 10-K · filed 2021-03-17 | |
| 2018-12-31 | $16.85M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.46M 10-Q · filed 2018-11-09 | |
| 2017-12-31 | $15.00M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $20.63M 10-K · filed 2018-03-21 | |
| 2015-12-31 | $14.27M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $7.28M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $5.80M 10-K · filed 2015-03-31 | $5.28M 10-K · filed 2014-03-31 |
| 2012-12-31 | $2.17M 10-K · filed 2014-03-31 | |
| 2011-12-31 | $1.00M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |